Public trial registry of the CCC-Munich

Trial Odonate

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
Odonate
World
Full title
:

A Multinational, Multicenter, Randomized, Phase 3 Study of Tesetaxel plus a Reduced Dose of Capecitabine versus Capecitabine Alone in Patients with HER2 Negative, Hormone
Receptor Positive, Locally Advanced or Metastatic Breast Cancer Previously Treated with a Taxane

World
EudraCT number
:
World
NCT number
:
World
Responsible organization
:
Frauenklinik GH, Telefon: 089440076800
Indications
Classification Code Description
- Breastcancer
Trial design
World
Trial type
:
Interventional
World
Blinding type
:
Open
World
Phase
:
III
Status
World
Status
:
Trial finished
Votes
World
Institutional review board - vote
:
Unknown
Initiiation & lock
World
Date of lock (planned / actual)
:
2021-06-28 / Unknown
Participants
Function Prename Surname Organization